Short contact treatment for acne

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514356, 514337, 514444, 514247, 514871, 514859, 536 243, 435 6, A01N 4340, A01N 4306, A01N 4358

Patent

active

060179384

ABSTRACT:
The present invention relates to a method of treating acne using short-term contact with an acetylenic retinoid, preferably tazarotene and related compounds.

REFERENCES:
patent: 5089509 (1992-02-01), Chandraratna
Leyden, James J., Emerging Topical Retinoid Therapies, Journal of the American Academy of Dermatology, Apr. 1998, vol. 38, No. 4, pp. S1-S4.
Chandraratna, R., Tazarotene--first of a new generation of receptor-selective retinoids, British Journal of Dermatology 1996, vol. 135, pp. 18-25.
Topical Retinoid Therapy, National Psoriasis Foundation, 1997, pp. 1-6.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Short contact treatment for acne does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Short contact treatment for acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short contact treatment for acne will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2316181

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.